Estadístiques de miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate

Visites totals

views
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate 173

Visites totals per mes

views
October 2024 0
November 2024 0
December 2024 0
January 2025 1
February 2025 1
March 2025 0
April 2025 0

Visites al fitxer

views
Ji_NC_miR.pdf(legacy) 163
Ji_NC_miR.pdf 31

Vistes principals per país

views
United States 129
Spain 12
Germany 9
France 7
Belgium 4
Czechia 4
Australia 3
China 2
Ireland 1
Saudi Arabia 1
Sweden 1

Visites principals per ciutat

views
Ashburn 29
Fairfield 25
San Ramon 22
Barcelona 11
Menlo Park 8
Cambridge 5
Mountain View 3
San Diego 3
Seattle 3
Boardman 2
Regensburg 2
Shenzhen 2
Tustin 2
Ann Arbor 1
Cupertino 1
Dallas 1
Dublin 1
Falls Church 1
Oakland 1
Phoenix 1
Redwood City 1
Riyadh 1
Rochester 1
Stockholm 1
Zaragoza 1